156 related articles for article (PubMed ID: 36158220)
1. Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for glioma.
Ouyang Z; Zhang H; Lin W; Su J; Wang X
Front Cell Dev Biol; 2022; 10():982439. PubMed ID: 36158220
[TBL] [Abstract][Full Text] [Related]
2. Identification of immune infiltration and cuproptosis-related subgroups in Crohn's disease.
Yuan Y; Fu M; Li N; Ye M
Front Immunol; 2022; 13():1074271. PubMed ID: 36466876
[TBL] [Abstract][Full Text] [Related]
3. Molecular subtypes of cuproptosis regulators and their correlation with clinical prognosis and immune response in glioma.
Zhang Y; Dai X; Li Z
Am J Transl Res; 2022; 14(11):8085-8102. PubMed ID: 36505293
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma.
Ye Z; Zhang S; Cai J; Ye L; Gao L; Wang Y; Tong S; Sun Q; Wu Y; Xiong X; Chen Q
Front Oncol; 2022; 12():967159. PubMed ID: 36059638
[TBL] [Abstract][Full Text] [Related]
5. A paradigm shift in cancer research based on integrative multi-omics approaches: glutaminase serves as a pioneering cuproptosis-related gene in pan-cancer.
Shi HH; Mugaanyi J; Lu C; Li Y; Huang J; Dai L
BMC Womens Health; 2024 Apr; 24(1):213. PubMed ID: 38566121
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Cuproptosis-Related Prognostic Signature and Associated Regulatory Axis in Uterine Corpus Endometrial Carcinoma.
Chen Y
Front Genet; 2022; 13():912037. PubMed ID: 35937995
[No Abstract] [Full Text] [Related]
7. A Cuproptosis Activation Scoring model predicts neoplasm-immunity interactions and personalized treatments in glioma.
Chen B; Zhou X; Yang L; Zhou H; Meng M; Zhang L; Li J
Comput Biol Med; 2022 Sep; 148():105924. PubMed ID: 35964468
[TBL] [Abstract][Full Text] [Related]
8. Cuproptosis key gene FDX1 is a prognostic biomarker and associated with immune infiltration in glioma.
Lu H; Zhou L; Zhang B; Xie Y; Yang H; Wang Z
Front Med (Lausanne); 2022; 9():939776. PubMed ID: 36523779
[TBL] [Abstract][Full Text] [Related]
9. A cuproptosis and copper metabolism-related gene prognostic index for head and neck squamous cell carcinoma.
Zhang S; Zhang L; Lu H; Yao Y; Liu X; Hou J
Front Oncol; 2022; 12():955336. PubMed ID: 36072790
[TBL] [Abstract][Full Text] [Related]
10. A Cuproptosis-Related Gene Model For Predicting the Prognosis of Clear Cell Renal Cell Carcinoma.
Mei W; Liu X; Jia X; Jin L; Xin S; Sun X; Zhang J; Zhang B; Chen Y; Che J; Ma W; Ye L
Front Genet; 2022; 13():905518. PubMed ID: 36092880
[TBL] [Abstract][Full Text] [Related]
11. Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction.
Liu Z; Wang L; Xing Q; Liu X; Hu Y; Li W; Yan Q; Liu R; Huang N
Front Cardiovasc Med; 2022; 9():1016081. PubMed ID: 36440046
[TBL] [Abstract][Full Text] [Related]
12. EREG is the core onco-immunological biomarker of cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma.
Zhou Y; Xiao D; Jiang X; Nie C
J Transl Med; 2023 Jan; 21(1):28. PubMed ID: 36647156
[TBL] [Abstract][Full Text] [Related]
13. A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma.
Yan X; Wang N; Dong J; Wang F; Zhang J; Hu X; Zhao H; Gao X; Liu Z; Li Y; Hu S
Front Mol Biosci; 2022; 9():966843. PubMed ID: 36060266
[TBL] [Abstract][Full Text] [Related]
14. The cuproptosis-related gene glutaminase promotes alveolar macrophage copper ion accumulation in chronic obstructive pulmonary disease.
Han L; Zhu W; Qi H; He L; Wang Q; Shen J; Song Y; Shen Y; Zhu Q; Zhou J
Int Immunopharmacol; 2024 Mar; 129():111585. PubMed ID: 38325045
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer genetic analysis of cuproptosis and copper metabolism-related gene set.
Liu H; Tang T
Front Oncol; 2022; 12():952290. PubMed ID: 36276096
[TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
Xu M; Mu J; Wang J; Zhou Q; Wang J
Front Oncol; 2022; 12():961213. PubMed ID: 35965536
[TBL] [Abstract][Full Text] [Related]
17. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer.
Feng A; He L; Chen T; Xu M
Front Oncol; 2022; 12():957966. PubMed ID: 36106123
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Analysis of Cuproptosis-Related Genes in Immune Infiltration and Prognosis in Melanoma.
Lv H; Liu X; Zeng X; Liu Y; Zhang C; Zhang Q; Xu J
Front Pharmacol; 2022; 13():930041. PubMed ID: 35837286
[TBL] [Abstract][Full Text] [Related]
19. Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer.
Li X; Ma Z; Mei L
Am J Cancer Res; 2022; 12(8):3561-3580. PubMed ID: 36119835
[TBL] [Abstract][Full Text] [Related]
20. Cuproptosis-Associated lncRNA Establishes New Prognostic Profile and Predicts Immunotherapy Response in Clear Cell Renal Cell Carcinoma.
Xu S; Liu D; Chang T; Wen X; Ma S; Sun G; Wang L; Chen S; Xu Y; Zhang H
Front Genet; 2022; 13():938259. PubMed ID: 35910212
[No Abstract] [Full Text] [Related]
[Next] [New Search]
